OTCPK:GBOK.F

Stock Analysis Report

Executive Summary

Greenbrook TMS Inc. operates outpatient mental health services centers in the United States.

Snowflake

Fundamentals

Adequate balance sheet and slightly overvalued.

Risks

  • Greenbrook TMS has significant price volatility in the past 3 months.
  • Greenbrook TMS is covered by less than 3 analysts.

Share Price & News

How has Greenbrook TMS's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:GBOK.F

0.8%

US Healthcare

1.3%

US Market


1 Year Return

n/a

OTCPK:GBOK.F

-8.2%

US Healthcare

2.0%

US Market

No trading data on GBOK.F.

No trading data on GBOK.F.


Share holder returns

GBOK.FIndustryMarket
7 Day0%0.8%1.3%
30 Day-3.0%-1.5%3.9%
90 Day-25.2%-0.5%3.4%
1 Yearn/a-6.8%-8.2%4.2%2.0%
3 Yearn/a30.2%24.9%47.2%37.6%
5 Yearn/a63.6%53.9%60.5%42.9%

Price Volatility Vs. Market

How volatile is Greenbrook TMS's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Greenbrook TMS undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Greenbrook TMS's share price is below the future cash flow value, and at a moderate discount (> 20%).

Greenbrook TMS's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Greenbrook TMS is loss making, we can't compare its value to the US Healthcare industry average.

Greenbrook TMS is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Greenbrook TMS, we can't assess if its growth is good value.


Price Based on Value of Assets

Greenbrook TMS is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Greenbrook TMS expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

52.8%

Forecasted annual revenue growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Greenbrook TMS's revenue is expected to grow significantly at over 20% yearly.

Unable to determine if Greenbrook TMS is high growth as no earnings estimate data is available.

Greenbrook TMS's revenue growth is expected to exceed the United States of America market average.

Unable to compare Greenbrook TMS's earnings growth to the United States of America market average as no estimate data is available.

Unable to compare Greenbrook TMS's earnings growth to the low risk savings rate as no estimate data is available.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Greenbrook TMS will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Greenbrook TMS performed over the past 5 years?

-36.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Greenbrook TMS does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Greenbrook TMS's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Greenbrook TMS's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Greenbrook TMS has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Greenbrook TMS has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Greenbrook TMS improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Greenbrook TMS's financial position?


Financial Position Analysis

Greenbrook TMS is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Greenbrook TMS's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Greenbrook TMS's level of debt (1.2%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Greenbrook TMS's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 95.9x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Greenbrook TMS has sufficient cash runway for 2.5 years based on current free cash flow.

Unable to confirm if Greenbrook TMS has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is Greenbrook TMS's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Greenbrook TMS's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Greenbrook TMS's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Greenbrook TMS has not reported any payouts.

Unable to verify if Greenbrook TMS's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Greenbrook TMS has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Greenbrook TMS's salary, the management and board of directors tenure and is there insider trading?

0.9yrs

Average board tenure


CEO

Bill Leonard (54yo)

0yrs

Tenure

US$429,167

Compensation

Mr. Bill Leonard serves as President and Chief Executive Officer of Greenbrook TMS Inc and also serves as Director from February 2018. Mr. Leonard is the President and Chief Executive Officer of TMS US, a  ...


CEO Compensation Analysis

Bill's remuneration is lower than average for companies of similar size in United States of America.

Insufficient data for Bill to compare compensation growth.


Board Age and Tenure

0.9yrs

Average Tenure

60.5yo

Average Age

The average tenure for the Greenbrook TMS board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Roberto Drassinower (55yo)

    Chief Operating Officer

    • Tenure: 0yrs
    • Compensation: US$287.49k
  • Erns Loubser

    CFO, Treasurer & Corporate Secretary

    • Tenure: 0yrs
    • Compensation: US$281.17k
  • Bill Leonard (54yo)

    President

    • Tenure: 0yrs
    • Compensation: US$429.17k
  • Geoffrey Grammer

    Chief Medical Officer

    • Tenure: 0yrs
    • Compensation: US$206.24k
  • Euphia Smith

    Chief Marketing Officer

    • Tenure: 0.7yrs

Board Members

  • Adele Oliva (52yo)

    Independent Director

    • Tenure: 0.3yrs
  • Frank Tworecke (72yo)

    Director

    • Tenure: 0.9yrs
    • Compensation: US$37.75k
  • Elias Vamvakas (60yo)

    Chairman Of The Board

    • Tenure: 1.6yrs
    • Compensation: US$75.50k
  • Adrienne Graves (66yo)

    Director

    • Tenure: 0.9yrs
    • Compensation: US$37.75k
  • Colleen Campbell (61yo)

    Lead Independent Director

    • Tenure: 0yrs
    • Compensation: US$45.30k
  • Brian Burke (63yo)

    Director

    • Tenure: 0.9yrs
    • Compensation: US$45.30k
  • Sasha Cucuz (41yo)

    Director

    • Tenure: 1yrs
    • Compensation: US$37.75k
  • Bill Leonard (54yo)

    President

    • Tenure: 0yrs
    • Compensation: US$429.17k

Company Information

Greenbrook TMS Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Greenbrook TMS Inc.
  • Ticker: GBOK.F
  • Exchange: OTCPK
  • Founded: 2011
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$133.793m
  • Listing Market Cap: CA$100.879m
  • Shares outstanding: 56.93m
  • Website: https://www.greenbrooktms.com

Number of Employees


Location

  • Greenbrook TMS Inc.
  • 890 Yonge Street
  • 7th Floor
  • Toronto
  • Ontario
  • M4W 3P4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GTMSTSX (The Toronto Stock Exchange)YesCommon SharesCACADOct 2018
GBOK.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDOct 2018

Biography

Greenbrook TMS Inc. operates outpatient mental health services centers in the United States. The company’s Greenbrook centers offer transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invas ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:29
End of Day Share Price2019/09/09 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.